Juan P. Alderuccio/X
Nov 4, 2024, 13:37
Juan P. Alderuccio: BTK inhibitors and degraders in Lymphoma and Chronic Lymphocytic Leukemia
Juan P. Alderuccio, Lymphoma Physician at Sylvester Comprehensive Cancer Center, shared on X about recent paper by him as co-author, titled “Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia” published on Nature Reviews Clinical Oncology.
Authors: Michele D. Stanchina, Skye Montoya, Alexey V. Danilov, Jorge J. Castillo, Alvaro J. Alencar, Julio C. Chavez, Chan Y. Cheah, Carlos Chiattone, Yucai Wang, Meghan Thompson, Paolo Ghia, Justin Taylor, Juan Pablo Alderuccio
“Happy to share our paper on BTK inhibitors and degraders in lymsm and CLL with the participation of outstanding colleagues.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 06:50
Apr 18, 2025, 03:14
Apr 18, 2025, 03:06
Apr 18, 2025, 02:16